MS. WILLEMIJN VAN DER SPUIJ
Willemijn van der Spuij is Executive Director Europe in the WorldWide Patient Safety Organization in Bristol Myers Squibb. She is responsible for Patient Safety in the EU markets, Balkans and Baltics.
Prior to this role she was responsible for EU markets, PV Intelligence & International Operations including the PSMF as well as Training and Outsourcing activities.
Willemijn holds a Nursing Degree from the Netherlands, a BA (Hons) in Sociology from Goldsmiths college, University of London, UK and an MSc in Pharmacovigilance from the University of Hertfordshire, UK.
She is a member of the EFPIA Pharmacovigilance Expert Working Group and Chair of the EFPIA International Pharmacovigilance Group. Willemijn is also involved in external PSMF activities and Clinical Trial (PV) activities. She started her career in industry in Quintiles in Clinical Research and moved to Pharmacovigilance in Bristol Myers Squibb in 2003.
Willemijn lives in Switzerland with her husband and son.